Spring Biological Technology Development Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A potential drug successfully treats the severe form of nonalcoholic fatty liver disease in non-human primates bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests. Nonalcoholic steatohepatitis (NASH) causes scarring and inflammation in the liver and is estimated to affect up to 6.5% of the global population. ....

United States , Wayne State University , Yang Zhao , Zuowen Zheng , Wanqing Liu , Chao Xue , Lemin Zheng , Enqi Liu , Liang Bai , Rong Zeng , Huiqing Wang , Zhipeng Lui , Sihai Zhao , Wenbin Cao , Mingming Zhao , Jifeng Zhang , Alexandrac Finney , Shuangshuang Chen , Xuelian Xiong , Eugene Chen , Ying Zhao , Chengshuang Chu , Duxin Sun , Linying Jia , Jinpeng Zhao , Bo Wen ,